{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:50:31Z","timestamp":1792025431811,"version":"4.4.0"},"reference-count":281,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T00:00:00Z","timestamp":1428969600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1038\/nrneph.2015.46","type":"journal-article","created":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T06:34:17Z","timestamp":1428993257000},"page":"515-534","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":128,"title":["The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease"],"prefix":"10.1038","volume":"11","author":[{"given":"Tamina","family":"Seeger-Nukpezah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Geynisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna S.","family":"Nikonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Benzing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica A.","family":"Golemis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,14]]},"reference":[{"key":"BFnrneph201546_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/ki.2009.128","volume":"76","author":"VE Torres","year":"2009","unstructured":"Torres, V. E. & Harris, P. C. Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int. 76, 149\u2013168 (2009).","journal-title":"Kidney Int."},{"key":"BFnrneph201546_CR2","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.ccr.2004.11.004","volume":"6","author":"B Weir","year":"2004","unstructured":"Weir, B., Zhao, X. & Meyerson, M. Somatic alterations in the human cancer genome. Cancer Cell 6, 433\u2013438 (2004).","journal-title":"Cancer Cell"},{"key":"BFnrneph201546_CR3","unstructured":"Howlader, N. et al. SEER cancer statistics review, 1975\u20132011. National Cancer Institute [online] , (2014)."},{"key":"BFnrneph201546_CR4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0272-6386(12)80507-5","volume":"15","author":"JJ Grantham","year":"1990","unstructured":"Grantham, J. J. Polycystic kidney disease: neoplasia in disguise. Am. J. Kidney Dis. 15, 110\u2013116 (1990).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201546_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd3078","volume":"9","author":"SM Paul","year":"2010","unstructured":"Paul, S. M. et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat. Rev. Drug Discov. 9, 203\u2013214 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnrneph201546_CR6","unstructured":"Mestre-Ferrandiz, J., Sussex, J. & Towse, A. The R&D cost of a new medicine. (Office of Health Economics, 2012)."},{"key":"BFnrneph201546_CR7","unstructured":"Grabowski, H. G. & Hansen, R. W. Innovation in the pharmaceutical industry: new estimates of R&D costs [online] , (2014)."},{"key":"BFnrneph201546_CR8","doi-asserted-by":"publisher","first-page":"12786","DOI":"10.1073\/pnas.1301904110","volume":"110","author":"T Seeger-Nukpezah","year":"2013","unstructured":"Seeger-Nukpezah, T. et al. Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease. Proc. Natl Acad. Sci. USA 110, 12786\u201312791 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201546_CR9","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature05348","volume":"444","author":"NO Bukanov","year":"2006","unstructured":"Bukanov, N. O. et al. Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine. Nature 444, 949\u2013952 (2006).","journal-title":"Nature"},{"key":"BFnrneph201546_CR10","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1681\/ASN.2007060665","volume":"19","author":"WE Sweeney Jr","year":"2008","unstructured":"Sweeney, W. E. Jr, et al. Src inhibition ameliorates polycystic kidney disease. J. Am. Soc. Nephrol. 19, 1331\u20131341 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201546_CR11","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1056\/NEJMoa0907419","volume":"363","author":"AL Serra","year":"2010","unstructured":"Serra, A. L. et al. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N. Engl. J. Med. 363, 820\u2013829 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201546_CR12","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1003491","volume":"363","author":"G Walz","year":"2010","unstructured":"Walz, G. et al. Everolimus in patients with autosomal dominant polycystic kidney disease. N. Engl. J. Med. 363, 830\u2013840 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201546_CR13","doi-asserted-by":"publisher","first-page":"21819","DOI":"10.1073\/pnas.0911987106","volume":"106","author":"Y Cao","year":"2009","unstructured":"Cao, Y. et al. Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models. Proc. Natl Acad. Sci. USA 106, 21819\u201321824 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201546_CR14","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1073\/pnas.0700499104","volume":"104","author":"SJ Leuenroth","year":"2007","unstructured":"Leuenroth, S. J. et al. Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease. Proc. Natl Acad. Sci. USA 104, 4389\u20134394 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201546_CR15","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1681\/ASN.2004090800","volume":"17","author":"S Omori","year":"2006","unstructured":"Omori, S. et al. Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease. J. Am. Soc. Nephrol. 17, 1604\u20131614 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201546_CR16","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1053\/j.ackd.2010.01.002","volume":"17","author":"AR Gallagher","year":"2010","unstructured":"Gallagher, A. R., Germino, G. G. & Somlo, S. Molecular advances in autosomal dominant polycystic kidney disease. Adv. Chronic Kidney Dis. 17, 118\u2013130 (2010).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"BFnrneph201546_CR17","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1083\/jcb.201006173","volume":"191","author":"HC Chapin","year":"2010","unstructured":"Chapin, H. C. & Caplan, M. J. The cell biology of polycystic kidney disease. J. Cell Biol. 191, 701\u2013710 (2010).","journal-title":"J. Cell Biol."},{"key":"BFnrneph201546_CR18","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1172\/JCI72272","volume":"124","author":"PC Harris","year":"2014","unstructured":"Harris, P. C. & Torres, V. E. Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease. J. Clin. Invest. 124, 2315\u20132324 (2014).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201546_CR19","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nrneph.2011.109","volume":"7","author":"JJ Grantham","year":"2011","unstructured":"Grantham, J. J., Mulamalla, S. & Swenson-Fields, K. I. Why kidneys fail in autosomal dominant polycystic kidney disease. Nat. Rev. Nephrol. 7, 556\u2013566 (2011).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph201546_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57\u201370 (2000).","journal-title":"Cell"},{"key":"BFnrneph201546_CR21","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"BFnrneph201546_CR22","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/ki.1987.121","volume":"31","author":"JJ Grantham","year":"1987","unstructured":"Grantham, J. J., Geiser, J. L. & Evan, A. P. Cyst formation and growth in autosomal dominant polycystic kidney disease. Kidney Int. 31, 1145\u20131152 (1987).","journal-title":"Kidney Int."},{"key":"BFnrneph201546_CR23","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1681\/ASN.V571462","volume":"5","author":"T Nadasdy","year":"1995","unstructured":"Nadasdy, T. et al. Proliferative activity of cyst epithelium in human renal cystic diseases. J. Am. Soc. Nephrol. 5, 1462\u20131468 (1995).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201546_CR24","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1093\/hmg\/ddm299","volume":"16","author":"IS Lantinga-van Leeuwen","year":"2007","unstructured":"Lantinga-van Leeuwen, I. S. et al. Kidney-specific inactivation of the Pkd1 gene induces rapid cyst formation in developing kidneys and a slow onset of disease in adult mice. Hum. Mol. Genet. 16, 3188\u20133196 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph201546_CR25","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.bbadis.2006.04.006","volume":"1762","author":"SJ Wilson","year":"2006","unstructured":"Wilson, S. J. et al. Inhibition of HER-2(neu\/ErbB2) restores normal function and structure to polycystic kidney disease (PKD) epithelia. Biochim. Biophys. Acta 1762, 647\u2013655 (2006).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrneph201546_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s004670000495","volume":"16","author":"K Nakanishi","year":"2001","unstructured":"Nakanishi, K. et al. Renal dysfunction but not cystic change is ameliorated by neonatal epidermal growth factor in bpk mice. Pediatr. Nephrol. 16, 45\u201350 (2001).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201546_CR27","doi-asserted-by":"publisher","first-page":"F944","DOI":"10.1152\/ajprenal.00387.2010","volume":"299","author":"T Yamaguchi","year":"2010","unstructured":"Yamaguchi, T. et al. Sorafenib inhibits cAMP-dependent ERK activation, cell proliferation, and in vitro cyst growth of human ADPKD cyst epithelial cells. Am. J. Physiol. Renal Physiol. 299, F944\u2013F951 (2010).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201546_CR28","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1046\/j.1523-1755.2000.00991.x","volume":"57","author":"T Yamaguchi","year":"2000","unstructured":"Yamaguchi, T. et al. cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. Kidney Int. 57, 1460\u20131471 (2000).","journal-title":"Kidney Int."},{"key":"BFnrneph201546_CR29","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.1073\/pnas.0509694103","volume":"103","author":"JM Shillingford","year":"2006","unstructured":"Shillingford, J. M. et al. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc. Natl Acad. Sci. USA 103, 5466\u20135471 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201546_CR30","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1681\/ASN.2009040421","volume":"21","author":"JM Shillingford","year":"2010","unstructured":"Shillingford, J. M. et al. Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1. J. Am. Soc. Nephrol. 21, 489\u2013497 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201546_CR31","first-page":"e23650","volume":"2","author":"T Weimbs","year":"2013","unstructured":"Weimbs, T., Olsan, E. E. & Talbot, J. J. Regulation of STATs by polycystin-1 and their role in polycystic kidney disease. JAKSTAT 2, e23650 (2013).","journal-title":"JAKSTAT"},{"key":"BFnrneph201546_CR32","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1681\/ASN.V181048","volume":"1","author":"BD Cowley Jr","year":"1991","unstructured":"Cowley, B. D. Jr, et al. Elevated proto-oncogene expression in polycystic kidneys of the C57BL\/6J (cpk) mouse. J. Am. Soc. Nephrol. 1, 1048\u20131053 (1991).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201546_CR33","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1681\/ASN.V371378","volume":"3","author":"T Nakamura","year":"1993","unstructured":"Nakamura, T. et al. Growth factor gene expression in kidney of murine polycystic kidney disease. J. Am. Soc. Nephrol. 3, 1378\u20131386 (1993).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201546_CR34","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/ki.1991.80","volume":"39","author":"M Trudel","year":"1991","unstructured":"Trudel, M., D'Agati, V. & Costantini, F. C-myc as an inducer of polycystic kidney disease in transgenic mice. Kidney Int. 39, 665\u2013671 (1991).","journal-title":"Kidney Int."},{"key":"BFnrneph201546_CR35","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1038\/nm1675","volume":"13","author":"K Piontek","year":"2007","unstructured":"Piontek, K. et al. A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1. Nat. Med. 13, 1490\u20131495 (2007).","journal-title":"Nat. Med."},{"key":"BFnrneph201546_CR36","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1093\/hmg\/ddp147","volume":"18","author":"A Takakura","year":"2009","unstructured":"Takakura, A. et al. Renal injury is a third hit promoting rapid development of adult polycystic kidney disease. Hum. Mol. Genet. 18, 2523\u20132531 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph201546_CR37","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1093\/hmg\/ddn045","volume":"17","author":"V Patel","year":"2008","unstructured":"Patel, V. et al. Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia. Hum. Mol. Genet. 17, 1578\u20131590 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph201546_CR38","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1093\/hmg\/ddn039","volume":"17","author":"S Shibazaki","year":"2008","unstructured":"Shibazaki, S. et al. Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1. Hum. Mol. Genet. 17, 1505\u20131516 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph201546_CR39","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","volume":"139","author":"KR Levental","year":"2009","unstructured":"Levental, K. R. et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139, 891\u2013906 (2009).","journal-title":"Cell"},{"key":"BFnrneph201546_CR40","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrc2544","volume":"9","author":"DT Butcher","year":"2009","unstructured":"Butcher, D. T., Alliston, T. & Weaver, V. M. A tense situation: forcing tumour progression. Nat. Rev. Cancer 9, 108\u2013122 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnrneph201546_CR41","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.bbadis.2011.06.012","volume":"1812","author":"J Norman","year":"2011","unstructured":"Norman, J. Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD). Biochim. Biophys. Acta 1812, 1327\u20131336 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrneph201546_CR42","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.clgc.2014.02.005","volume":"12","author":"PV Nuzzo","year":"2014","unstructured":"Nuzzo, P. V. et al. Periostin: a novel prognostic and therapeutic target for genitourinary cancer? Clin. Genitourin. Cancer 12, 301\u2013311 (2014).","journal-title":"Clin. Genitourin. Cancer"},{"key":"BFnrneph201546_CR43","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/ki.2013.488","volume":"85","author":"DP Wallace","year":"2014","unstructured":"Wallace, D. P. et al. Periostin promotes renal cyst growth and interstitial fibrosis in polycystic kidney disease. Kidney Int. 85, 845\u2013854 (2014).","journal-title":"Kidney Int."},{"key":"BFnrneph201546_CR44","doi-asserted-by":"publisher","unstructured":"Lee, K. et al. Inactivation of integrin-\u03b21 prevents the development of polycystic kidney disease after the loss of polycystin-1. J. Am. Soc. Nephrol. http:\/\/dx.doi.org\/10.1681\/ASN.2013111179 .","DOI":"10.1681\/ASN.2013111179"},{"key":"BFnrneph201546_CR45","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ceb.2012.06.002","volume":"24","author":"T Seeger-Nukpezah","year":"2012","unstructured":"Seeger-Nukpezah, T. & Golemis, E. A. The extracellular matrix and ciliary signaling. Curr. Opin. Cell Biol. 24, 652\u2013661 (2012).","journal-title":"Curr. Opin. Cell Biol."},{"key":"BFnrneph201546_CR46","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1172\/JCI22850","volume":"115","author":"S Nishio","year":"2005","unstructured":"Nishio, S. et al. Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation. J. Clin. Invest. 115, 910\u2013918 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201546_CR47","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1172\/JCI64401","volume":"123","author":"X Zhou","year":"2013","unstructured":"Zhou, X. et al. Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease. J. Clin. Invest. 123, 3084\u20133098 (2013).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201546_CR48","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ki.2011.296","volume":"81","author":"LX Fan","year":"2012","unstructured":"Fan, L. X. et al. Inhibition of histone deacetylases targets the transcription regulator Id2 to attenuate cystic epithelial cell proliferation. Kidney Int. 81, 76\u201385 (2012).","journal-title":"Kidney Int."},{"key":"BFnrneph201546_CR49","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0092-8674(02)00716-X","volume":"109","author":"AK Bhunia","year":"2002","unstructured":"Bhunia, A. K. et al. PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2. Cell 109, 157\u2013168 (2002).","journal-title":"Cell"},{"key":"BFnrneph201546_CR50","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2369-8-12","volume":"8","author":"JY Park","year":"2007","unstructured":"Park, J. Y. et al. p21 is decreased in polycystic kidney disease and leads to increased epithelial cell cycle progression: roscovitine augments p21 levels. BMC Nephrol. 8, 12 (2007).","journal-title":"BMC Nephrol."},{"key":"BFnrneph201546_CR51","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2369-9-10","volume":"9","author":"KN Felekkis","year":"2008","unstructured":"Felekkis, K. N. et al. Mutant polycystin-2 induces proliferation in primary rat tubular epithelial cells in a STAT-1\/p21-independent fashion accompanied instead by alterations in expression of p57KIP2 and Cdk2. BMC Nephrol. 9, 10 (2008).","journal-title":"BMC Nephrol."},{"key":"BFnrneph201546_CR52","doi-asserted-by":"crossref","unstructured":"The European Polycystic Kidney Disease Consortium. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 77, 881\u2013894 (1994).","DOI":"10.1016\/0092-8674(94)90137-6"},{"key":"BFnrneph201546_CR53","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/ng1294-328","volume":"8","author":"PT Brook-Carter","year":"1994","unstructured":"Brook-Carter, P. T. et al. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease\u2014a contiguous gene syndrome. Nat. Genet. 8, 328\u2013332 (1994).","journal-title":"Nat. Genet."},{"key":"BFnrneph201546_CR54","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1755-8417-2-6","volume":"2","author":"A Boletta","year":"2009","unstructured":"Boletta, A. Emerging evidence of a link between the polycystins and the mTOR pathways. Pathogenetics 2, 6 (2009).","journal-title":"Pathogenetics"},{"key":"BFnrneph201546_CR55","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/ncb2117","volume":"12","author":"C Boehlke","year":"2010","unstructured":"Boehlke, C. et al. Primary cilia regulate mTORC1 activity and cell size through Lkb1. Nat. Cell Biol. 12, 1115\u20131122 (2010).","journal-title":"Nat. Cell Biol."},{"key":"BFnrneph201546_CR56","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/nm.3092","volume":"19","author":"I Rowe","year":"2013","unstructured":"Rowe, I. et al. Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy. Nat. Med. 19, 488\u2013493 (2013).","journal-title":"Nat. Med."},{"key":"BFnrneph201546_CR57","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.devcel.2010.03.007","volume":"18","author":"X Varelas","year":"2010","unstructured":"Varelas, X. et al. The Hippo pathway regulates Wnt\/beta-catenin signaling. Dev. Cell 18, 579\u2013591 (2010).","journal-title":"Dev. Cell"},{"key":"BFnrneph201546_CR58","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1083\/jcb.201009069","volume":"193","author":"S Habbig","year":"2011","unstructured":"Habbig, S. et al. NPHP4, a cilia-associated protein, negatively regulates the Hippo pathway. J. Cell Biol. 193, 633\u2013642 (2011).","journal-title":"J. Cell Biol."},{"key":"BFnrneph201546_CR59","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.devcel.2010.09.011","volume":"19","author":"D Pan","year":"2010","unstructured":"Pan, D. The hippo signaling pathway in development and cancer. Dev. Cell 19, 491\u2013505 (2010).","journal-title":"Dev. Cell"},{"key":"BFnrneph201546_CR60","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.cell.2014.06.029","volume":"158","author":"NJ Ganem","year":"2014","unstructured":"Ganem, N. J. et al. Cytokinesis failure triggers hippo tumor suppressor pathway activation. Cell 158, 833\u2013848 (2014).","journal-title":"Cell"},{"key":"BFnrneph201546_CR61","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1126\/science.281.5381.1322","volume":"281","author":"JM Adams","year":"1998","unstructured":"Adams, J. M. & Cory, S. The Bcl-2 protein family: arbiters of cell survival. Science 281, 1322\u20131326 (1998).","journal-title":"Science"},{"key":"BFnrneph201546_CR62","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s00262-011-1008-4","volume":"60","author":"TJ Sayers","year":"2011","unstructured":"Sayers, T. J. Targeting the extrinsic apoptosis signaling pathway for cancer therapy. Cancer Immunol. Immunother. 60, 1173\u20131180 (2011).","journal-title":"Cancer Immunol. Immunother."},{"key":"BFnrneph201546_CR63","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrm3735","volume":"15","author":"G Marino","year":"2014","unstructured":"Marino, G. et al. Self-consumption: the interplay of autophagy and apoptosis. Nat. Rev. Mol. Cell Biol. 15, 81\u201394 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnrneph201546_CR64","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.semcdb.2014.02.006","volume":"35","author":"L Galluzzi","year":"2014","unstructured":"Galluzzi, L. et al. Molecular mechanisms of regulated necrosis. Semin. Cell Dev. Biol. 35, 24\u201332 (2014).","journal-title":"Semin. Cell Dev. Biol."},{"key":"BFnrneph201546_CR65","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrm3737","volume":"15","author":"T Vanden Berghe","year":"2014","unstructured":"Vanden Berghe, T. et al. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat. Rev. Mol. Cell Biol. 15, 135\u2013147 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnrneph201546_CR66","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1681\/ASN.2013020176","volume":"24","author":"LX Fan","year":"2013","unstructured":"Fan, L. X. et al. Smac-mimetic-induced epithelial cell death reduces the growth of renal cysts. J. Am. Soc. Nephrol. 24, 2010\u20132022 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201546_CR67","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.bbadis.2011.01.006","volume":"1812","author":"B Goilav","year":"2011","unstructured":"Goilav, B. Apoptosis in polycystic kidney disease. Biochim. Biophys. Acta 1812, 1272\u20131280 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrneph201546_CR68","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1056\/NEJM199507063330104","volume":"333","author":"D Woo","year":"1995","unstructured":"Woo, D. Apoptosis and loss of renal tissue in polycystic kidney diseases. N. Engl. J. Med. 333, 18\u201325 (1995).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201546_CR69","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0092-8674(93)80065-M","volume":"75","author":"DJ Veis","year":"1993","unstructured":"Veis, D. J. et al. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75, 229\u2013240 (1993).","journal-title":"Cell"},{"key":"BFnrneph201546_CR70","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/sj.cdd.4401815","volume":"13","author":"P Hughes","year":"2006","unstructured":"Hughes, P. et al. Loss of PKD1 and loss of Bcl-2 elicit polycystic kidney disease through distinct mechanisms. Cell Death Differ. 13, 1123\u20131127 (2006).","journal-title":"Cell Death Differ."},{"key":"BFnrneph201546_CR71","doi-asserted-by":"publisher","first-page":"10243","DOI":"10.1074\/jbc.M109.070821","volume":"285","author":"W Yu","year":"2010","unstructured":"Yu, W. et al. Polycystin-1 protein level determines activity of the Galpha12\/JNK apoptosis pathway. J. Biol. Chem. 285, 10243\u201310251 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201546_CR72","doi-asserted-by":"publisher","first-page":"6954","DOI":"10.1073\/pnas.0408518102","volume":"102","author":"Y Tao","year":"2005","unstructured":"Tao, Y. et al. Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease. Proc. Natl Acad. Sci. USA 102, 6954\u20136959 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201546_CR73","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nature12639","volume":"502","author":"O Pampliega","year":"2013","unstructured":"Pampliega, O. et al. Functional interaction between autophagy and ciliogenesis. Nature 502, 194\u2013200 (2013).","journal-title":"Nature"},{"key":"BFnrneph201546_CR74","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nature12606","volume":"502","author":"Z Tang","year":"2013","unstructured":"Tang, Z. et al. Autophagy promotes primary ciliogenesis by removing OFD1 from centriolar satellites. Nature 502, 254\u2013257 (2013).","journal-title":"Nature"},{"key":"BFnrneph201546_CR75","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.semnephrol.2013.11.005","volume":"34","author":"K Ravichandran","year":"2014","unstructured":"Ravichandran, K. & Edelstein, C. L. Polycystic kidney disease: a case of suppressed autophagy? Semin. Nephrol. 34, 27\u201333 (2014).","journal-title":"Semin. Nephrol."},{"key":"BFnrneph201546_CR76","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nm1783","volume":"14","author":"X Li","year":"2008","unstructured":"Li, X. et al. A tumor necrosis factor-\u03b1-mediated pathway promoting autosomal dominant polycystic kidney disease. Nat. Med. 14, 863\u2013868 (2008).","journal-title":"Nat. Med."},{"key":"BFnrneph201546_CR77","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s00018-011-0910-4","volume":"69","author":"CH Coschi","year":"2012","unstructured":"Coschi, C. H. & Dick, F. A. Chromosome instability and deregulated proliferation: an unavoidable duo. Cell. Mol. Life Sci. 69, 2009\u20132024 (2012).","journal-title":"Cell. Mol. Life Sci."},{"key":"BFnrneph201546_CR78","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","volume":"153","author":"C Lopez-Otin","year":"2013","unstructured":"Lopez-Otin, C. et al. The hallmarks of aging. Cell 153, 1194\u20131217 (2013).","journal-title":"Cell"},{"key":"BFnrneph201546_CR79","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nm.3447","volume":"20","author":"E Verdin","year":"2014","unstructured":"Verdin, E. The many faces of sirtuins: coupling of NAD metabolism, sirtuins and lifespan. Nat. Med. 20, 25\u201327 (2014).","journal-title":"Nat. Med."},{"key":"BFnrneph201546_CR80","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/onc.2013.120","volume":"33","author":"M Roth","year":"2014","unstructured":"Roth, M. & Chen, W. Y. Sorting out functions of sirtuins in cancer. Oncogene 33, 1609\u20131620 (2014).","journal-title":"Oncogene"},{"key":"BFnrneph201546_CR81","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/sj.ki.5002229","volume":"72","author":"E Parker","year":"2007","unstructured":"Parker, E. et al. Hyperproliferation of PKD1 cystic cells is induced by insulin-like growth factor-1 activation of the Ras\/Raf signalling system. Kidney Int. 72, 157\u2013165 (2007).","journal-title":"Kidney Int."},{"key":"BFnrneph201546_CR82","first-page":"1051","volume":"142","author":"DL Schaffner","year":"1993","unstructured":"Schaffner, D. L. et al. Targeting of the rasT24 oncogene to the proximal convoluted tubules in transgenic mice results in hyperplasia and polycystic kidneys. Am. J. Pathol. 142, 1051\u20131060 (1993).","journal-title":"Am. J. Pathol."},{"key":"BFnrneph201546_CR83","doi-asserted-by":"publisher","first-page":"40419","DOI":"10.1074\/jbc.M405079200","volume":"279","author":"T Yamaguchi","year":"2004","unstructured":"Yamaguchi, T. et al. Calcium restriction allows cAMP activation of the B-Raf\/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype. J. Biol. Chem. 279, 40419\u201340430 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph201546_CR84","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.1200\/JCO.2004.05.061","volume":"22","author":"WY Kim","year":"2004","unstructured":"Kim, W. Y. & Kaelin, W. G. Role of VHL gene mutation in human cancer. J. Clin. Oncol. 22, 4991\u20135004 (2004).","journal-title":"J. Clin. Oncol."},{"key":"BFnrneph201546_CR85","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1158\/0008-5472.CAN-05-3241","volume":"66","author":"EB Rankin","year":"2006","unstructured":"Rankin, E. B., Tomaszewski, J. E. & Haase, V. H. Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor. Cancer Res. 66, 2576\u20132583 (2006).","journal-title":"Cancer Res."},{"key":"BFnrneph201546_CR86","doi-asserted-by":"publisher","first-page":"16538","DOI":"10.1073\/pnas.1414789111","volume":"111","author":"SS Wang","year":"2014","unstructured":"Wang, S. S. et al. Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis. Proc. Natl Acad. Sci. USA 111, 16538\u201316543 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201546_CR87","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/ncb1699","volume":"10","author":"AP Young","year":"2008","unstructured":"Young, A. P. et al. VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400. Nat. Cell Biol. 10, 361\u2013369 (2008).","journal-title":"Nat. Cell Biol."},{"key":"BFnrneph201546_CR88","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1681\/ASN.2009050497","volume":"20","author":"RU Muller","year":"2009","unstructured":"Muller, R. U. et al. The von Hippel Lindau tumor suppressor limits longevity. J. Am. Soc. Nephrol. 20, 2513\u20132517 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201546_CR89","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1126\/science.1173507","volume":"324","author":"R Mehta","year":"2009","unstructured":"Mehta, R. et al. Proteasomal regulation of the hypoxic response modulates aging in C. elegans. Science 324, 1196\u20131198 (2009).","journal-title":"Science"},{"key":"BFnrneph201546_CR90","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1053\/j.ackd.2010.01.003","volume":"17","author":"Y Pirson","year":"2010","unstructured":"Pirson, Y. Extrarenal manifestations of autosomal dominant polycystic kidney disease. Adv. Chronic Kidney Dis. 17, 173\u2013180 (2010).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"BFnrneph201546_CR91","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1046\/j.1523-1755.2001.00768.x","volume":"60","author":"E Bello-Reuss","year":"2001","unstructured":"Bello-Reuss, E., Holubec, E. K. & Rajaraman, S. Angiogenesis in autosomal-dominant polycystic kidney disease. Kidney Int. 60, 37\u201345 (2001).","journal-title":"Kidney Int."},{"key":"BFnrneph201546_CR92","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/sj.ki.5001725","volume":"70","author":"W Wei","year":"2006","unstructured":"Wei, W. et al. Evidence of angiogenesis and microvascular regression in autosomal-dominant polycystic kidney disease kidneys: a corrosion cast study. Kidney Int. 70, 1261\u20131268 (2006).","journal-title":"Kidney Int."},{"key":"BFnrneph201546_CR93","doi-asserted-by":"publisher","first-page":"830","DOI":"10.2353\/ajpath.2007.060455","volume":"170","author":"WM Bernhardt","year":"2007","unstructured":"Bernhardt, W. M. et al. Involvement of hypoxia-inducible transcription factors in polycystic kidney disease. Am. J. Pathol. 170, 830\u2013842 (2007).","journal-title":"Am. J. Pathol."},{"key":"BFnrneph201546_CR94","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/sj.ki.5002550","volume":"72","author":"Y Tao","year":"2007","unstructured":"Tao, Y. et al. VEGF receptor inhibition slows the progression of polycystic kidney disease. Kidney Int. 72, 1358\u20131366 (2007).","journal-title":"Kidney Int."},{"key":"BFnrneph201546_CR95","doi-asserted-by":"publisher","first-page":"F1235","DOI":"10.1152\/ajprenal.00348.2010","volume":"300","author":"F Belibi","year":"2011","unstructured":"Belibi, F. et al. Hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1) and autophagy in polycystic kidney disease (PKD). Am. J. Physiol. Renal Physiol. 300, F1235\u2013F1243 (2011).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201546_CR96","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/ki.2010.355","volume":"79","author":"BY Reed","year":"2011","unstructured":"Reed, B. Y. et al. Angiogenic growth factors correlate with disease severity in young patients with autosomal dominant polycystic kidney disease. Kidney Int. 79, 128\u2013134 (2011).","journal-title":"Kidney Int."},{"key":"BFnrneph201546_CR97","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1073\/pnas.040550097","volume":"97","author":"K Kim","year":"2000","unstructured":"Kim, K. et al. Polycystin 1 is required for the structural integrity of blood vessels. Proc. Natl Acad. Sci. USA 97, 1731\u20131736 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201546_CR98","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.celrep.2014.03.064","volume":"7","author":"P Outeda","year":"2014","unstructured":"Outeda, P. et al. Polycystin signaling is required for directed endothelial cell migration and lymphatic development. Cell Rep. 7, 634\u2013644 (2014).","journal-title":"Cell Rep."},{"key":"BFnrneph201546_CR99","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.bbrc.2014.01.068","volume":"444","author":"I Rowe","year":"2014","unstructured":"Rowe, I. et al. Impaired glomerulogenesis and endothelial cell migration in Pkd1-deficient renal organ cultures. Biochem. Biophys. Res. Commun. 444, 473\u2013479 (2014).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrneph201546_CR100","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.celrep.2014.03.063","volume":"7","author":"B Coxam","year":"2014","unstructured":"Coxam, B. et al. Pkd1 regulates lymphatic vascular morphogenesis during development. Cell Rep. 7, 623\u2013633 (2014).","journal-title":"Cell Rep."},{"key":"BFnrneph201546_CR101","doi-asserted-by":"publisher","first-page":"F773","DOI":"10.1152\/ajprenal.00058.2011","volume":"301","author":"S Raina","year":"2011","unstructured":"Raina, S. et al. Anti-VEGF antibody treatment accelerates polycystic kidney disease. Am. J. Physiol. Renal Physiol. 301, F773\u2013F783 (2011).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201546_CR102","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.semcdb.2012.02.003","volume":"23","author":"SJ Bensinger","year":"2012","unstructured":"Bensinger, S. J. & Christofk, H. R. New aspects of the Warburg effect in cancer cell biology. Semin. Cell Dev. Biol. 23, 352\u2013361 (2012).","journal-title":"Semin. Cell Dev. Biol."},{"key":"BFnrneph201546_CR103","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1093\/ndt\/gft521","volume":"29","author":"I Rowe","year":"2014","unstructured":"Rowe, I. & Boletta, A. Defective metabolism in polycystic kidney disease: potential for therapy and open questions. Nephrol. Dial. Transplant. 29, 1480\u20131486 (2014).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201546_CR104","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/ndt\/gfu044","volume":"30","author":"Z Mao","year":"2014","unstructured":"Mao, Z., Xie, G. & Ong, A. C. Metabolic abnormalities in autosomal dominant polycystic kidney disease. Nephrol. Dial. Transplant. 30, 197\u2013203 (2014).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201546_CR105","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/ki.2013.199","volume":"84","author":"X Wang","year":"2013","unstructured":"Wang, X. et al. Targeting of sodium-glucose cotransporters with phlorizin inhibits polycystic kidney disease progression in Han:SPRD rats. Kidney Int. 84, 962\u2013968 (2013).","journal-title":"Kidney Int."},{"key":"BFnrneph201546_CR106","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1126\/science.122.3168.501","volume":"122","author":"H Eagle","year":"1955","unstructured":"Eagle, H. Nutrition needs of mammalian cells in tissue culture. Science 122, 501\u2013514 (1955).","journal-title":"Science"},{"key":"BFnrneph201546_CR107","doi-asserted-by":"publisher","first-page":"19345","DOI":"10.1073\/pnas.0709747104","volume":"104","author":"RJ DeBerardinis","year":"2007","unstructured":"DeBerardinis, R. J. et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl Acad. Sci. USA 104, 19345\u201319350 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201546_CR108","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.4155\/fmc.13.130","volume":"5","author":"MJ Lukey","year":"2013","unstructured":"Lukey, M. J., Wilson, K. F. & Cerione, R. A. Therapeutic strategies impacting cancer cell glutamine metabolism. Future Med. Chem. 5, 1685\u20131700 (2013).","journal-title":"Future Med. Chem."},{"key":"BFnrneph201546_CR109","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.2967\/jnumed.111.093815","volume":"52","author":"BP Lieberman","year":"2011","unstructured":"Lieberman, B. P. et al. PET imaging of glutaminolysis in tumors by 18F-(2S, 4R)4-fluoroglutamine. J. Nucl. Med. 52, 1947\u20131955 (2011).","journal-title":"J. Nucl. Med."},{"key":"BFnrneph201546_CR110","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","volume":"21","author":"D Hanahan","year":"2012","unstructured":"Hanahan, D. & Coussens, L. M. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21, 309\u2013322 (2012).","journal-title":"Cancer Cell"},{"key":"BFnrneph201546_CR111","first-page":"399","volume":"103","author":"AA Werder","year":"1984","unstructured":"Werder, A. A. et al. Comparative effects of germfree and ambient environments on the development of cystic kidney disease in CFWwd mice. J. Lab. Clin. Med. 103, 399\u2013407 (1984).","journal-title":"J. Lab. Clin. Med."},{"key":"BFnrneph201546_CR112","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/ki.1991.87","volume":"39","author":"KD Gardner Jr","year":"1991","unstructured":"Gardner, K. D. Jr et al. Cytokines in fluids from polycystic kidneys. Kidney Int. 39, 718\u2013724 (1991).","journal-title":"Kidney Int."},{"key":"BFnrneph201546_CR113","first-page":"619","volume":"41","author":"M Merta","year":"1997","unstructured":"Merta, M. et al. Cytokine profile in autosomal dominant polycystic kidney disease. Biochem. Mol. Biol. Int. 41, 619\u2013624 (1997).","journal-title":"Biochem. Mol. Biol. Int."},{"key":"BFnrneph201546_CR114","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1046\/j.1523-1755.2001.00065.x","volume":"60","author":"BD Cowley Jr","year":"2001","unstructured":"Cowley, B. D. Jr et al. Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats. Kidney Int. 60, 2087\u20132096 (2001).","journal-title":"Kidney Int."},{"key":"BFnrneph201546_CR115","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1681\/ASN.2011010084","volume":"22","author":"A Karihaloo","year":"2011","unstructured":"Karihaloo, A. et al. Macrophages promote cyst growth in polycystic kidney disease. J. Am. Soc. Nephrol. 22, 1809\u20131814 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201546_CR116","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/ki.2012.446","volume":"83","author":"KI Swenson-Fields","year":"2013","unstructured":"Swenson-Fields, K. I. et al. Macrophages promote polycystic kidney disease progression. Kidney Int. 83, 855\u2013864 (2013).","journal-title":"Kidney Int."},{"key":"BFnrneph201546_CR117","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/sj.ki.5002627","volume":"73","author":"M Mrug","year":"2008","unstructured":"Mrug, M. et al. Overexpression of innate immune response genes in a model of recessive polycystic kidney disease. Kidney Int. 73, 63\u201376 (2008).","journal-title":"Kidney Int."},{"key":"BFnrneph201546_CR118","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1681\/ASN.2011050442","volume":"23","author":"J Zhou","year":"2012","unstructured":"Zhou, J. et al. Kidney injury accelerates cystogenesis via pathways modulated by heme oxygenase and complement. J. Am. Soc. Nephrol. 23, 1161\u20131171 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201546_CR119","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1172\/JCI119147","volume":"99","author":"JL Brasier","year":"1997","unstructured":"Brasier, J. L. & Henske, E. P. Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis. J. Clin. Invest. 99, 194\u2013199 (1997).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201546_CR120","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1086\/302501","volume":"65","author":"R Torra","year":"1999","unstructured":"Torra, R. et al. A loss-of-function model for cystogenesis in human autosomal dominant polycystic kidney disease type 2. Am. J. Hum. Genet. 65, 345\u2013352 (1999).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneph201546_CR121","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1681\/ASN.V1071524","volume":"10","author":"Y Pei","year":"1999","unstructured":"Pei, Y. et al. Somatic PKD2 mutations in individual kidney and liver cysts support a \u201ctwo-hit\u201d model of cystogenesis in type 2 autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 10, 1524\u20131529 (1999).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201546_CR122","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1073\/pnas.72.12.5116","volume":"72","author":"AG Knudson Jr","year":"1975","unstructured":"Knudson, A. G. Jr, Hethcote, H. W. & Brown, B. W. Mutation and childhood cancer: a probabilistic model for the incidence of retinoblastoma. Proc. Natl Acad. Sci. USA 72, 5116\u20135120 (1975).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201546_CR123","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00439-013-1378-0","volume":"133","author":"YM Woo","year":"2014","unstructured":"Woo, Y. M. et al. Genome-wide methylation profiling of ADPKD identified epigenetically regulated genes associated with renal cyst development. Hum. Genet. 133, 281\u2013297 (2014).","journal-title":"Hum. Genet."},{"key":"BFnrneph201546_CR124","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1093\/hmg\/ddn180","volume":"17","author":"L Battini","year":"2008","unstructured":"Battini, L. et al. Loss of polycystin-1 causes centrosome amplification and genomic instability. Hum. Mol. Genet. 17, 2819\u20132833 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph201546_CR125","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1161\/CIRCULATIONAHA.113.005746","volume":"129","author":"WA Aboualaiwi","year":"2014","unstructured":"Aboualaiwi, W. A. et al. Survivin-induced abnormal ploidy contributes to cystic kidney and aneurysm formation. Circulation 129, 660\u2013672 (2014).","journal-title":"Circulation"},{"key":"BFnrneph201546_CR126","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/hmg\/ddq470","volume":"20","author":"WA AbouAlaiwi","year":"2011","unstructured":"AbouAlaiwi, W. A. et al. Endothelial cells from humans and mice with polycystic kidney disease are characterized by polyploidy and chromosome segregation defects through survivin down-regulation. Hum. Mol. Genet. 20, 354\u2013367 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneph201546_CR127","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/0300060513475956","volume":"41","author":"M Li","year":"2013","unstructured":"Li, M. et al. Genomic instability in patients with autosomal-dominant polycystic kidney disease. J. Int. Med. Res. 41, 169\u2013175 (2013).","journal-title":"J. Int. Med. Res."},{"key":"BFnrneph201546_CR128","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1681\/ASN.V10112342","volume":"10","author":"DM Reynolds","year":"1999","unstructured":"Reynolds, D. M. et al. Aberrant splicing in the PKD2 gene as a cause of polycystic kidney disease. J. Am. Soc. Nephrol. 10, 2342\u20132351 (1999).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201546_CR129","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1096\/fj.03-0687fje","volume":"18","author":"G Aguiari","year":"2004","unstructured":"Aguiari, G. et al., Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells. FASEB J. 18, 884\u2013886 (2004).","journal-title":"FASEB J."},{"key":"BFnrneph201546_CR130","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/(SICI)1096-8628(19961016)65:2<155::AID-AJMG15>3.0.CO;2-P","volume":"65","author":"S Rossetti","year":"1996","unstructured":"Rossetti, S. et al. Autosomal dominant polycystic kidney disease (ADPKD) in an Italian family carrying a novel nonsense mutation and two missense changes in exons 44 and 45 of the PKD1 gene. Am. J. Med. Genet. 65, 155\u2013159 (1996).","journal-title":"Am. J. Med. Genet."},{"key":"BFnrneph201546_CR131","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.cell.2012.06.028","volume":"150","author":"M Chaki","year":"2012","unstructured":"Chaki, M. et al. Exome capture reveals ZNF423 and CEP164 mutations, linking renal ciliopathies to DNA damage response signaling. Cell 150, 533\u2013548 (2012).","journal-title":"Cell"},{"key":"BFnrneph201546_CR132","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.molcel.2013.08.006","volume":"51","author":"HJ Choi","year":"2013","unstructured":"Choi, H. J. et al. NEK8 links the ATR-regulated replication stress response and S phase CDK activity to renal ciliopathies. Mol. Cell 51, 423\u2013439 (2013).","journal-title":"Mol. Cell"},{"key":"BFnrneph201546_CR133","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1681\/ASN.2013050565","volume":"25","author":"R Airik","year":"2014","unstructured":"Airik, R. et al. Renal-retinal ciliopathy gene Sdccag8 Regulates DNA damage response signaling. J. Am. Soc. Nephrol. 25, 2573\u20132583 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201546_CR134","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1158\/0008-5472.CAN-12-1752","volume":"73","author":"M Kaucka","year":"2013","unstructured":"Kaucka, M. et al. The planar cell polarity pathway drives pathogenesis of chronic lymphocytic leukemia by the regulation of B-lymphocyte migration. Cancer Res. 73, 1491\u20131501 (2013).","journal-title":"Cancer Res."},{"key":"BFnrneph201546_CR135","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.cell.2012.11.024","volume":"151","author":"V Luga","year":"2012","unstructured":"Luga, V. et al. Exosomes mediate stromal mobilization of autocrine Wnt\u2013PCP signaling in breast cancer cell migration. Cell 151, 1542\u20131556 (2012).","journal-title":"Cell"},{"key":"BFnrneph201546_CR136","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.3892\/or.14.1.291","volume":"14","author":"M Katoh","year":"2005","unstructured":"Katoh, M. WNT\/PCP signaling pathway and human cancer. Oncol. Rep, 14, 1583\u20131588 (2005).","journal-title":"Oncol. Rep"},{"key":"BFnrneph201546_CR137","doi-asserted-by":"publisher","first-page":"e1001720","DOI":"10.1371\/journal.pbio.1001720","volume":"11","author":"C Cui","year":"2013","unstructured":"Cui, C. et al. Wdpcp, a PCP protein required for ciliogenesis, regulates directional cell migration and cell polarity by direct modulation of the actin cytoskeleton. PLoS Biol. 11, e1001720 (2013).","journal-title":"PLoS Biol."},{"key":"BFnrneph201546_CR138","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.diff.2011.11.012","volume":"83","author":"S Lienkamp","year":"2012","unstructured":"Lienkamp, S., Ganner, A. & Walz, G. Inversin, Wnt signaling and primary cilia. Differentiation 83, S49\u2013S55 (2012).","journal-title":"Differentiation"},{"key":"BFnrneph201546_CR139","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.bbadis.2011.05.008","volume":"1812","author":"PD Wilson","year":"2011","unstructured":"Wilson, P. D. Apico-basal polarity in polycystic kidney disease epithelia. Biochim. Biophys. Acta 1812, 1239\u20131248 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrneph201546_CR140","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4161\/org.26766","volume":"10","author":"P Goggolidou","year":"2014","unstructured":"Goggolidou, P. Wnt and planar cell polarity signaling in cystic renal disease. Organogenesis 10, 86\u201395 (2014).","journal-title":"Organogenesis"},{"key":"BFnrneph201546_CR141","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s00467-012-2337-z","volume":"28","author":"S Fedeles","year":"2013","unstructured":"Fedeles, S. & Gallagher, A. R. Cell polarity and cystic kidney disease. Pediatr. Nephrol. 28, 1161\u20131172 (2013).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph201546_CR142","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/nm.2010","volume":"15","author":"MA Lancaster","year":"2009","unstructured":"Lancaster, M. A. et al. Impaired Wnt-\u03b2-catenin signaling disrupts adult renal homeostasis and leads to cystic kidney ciliopathy. Nat. Med. 15, 1046\u20131054 (2009).","journal-title":"Nat. Med."},{"key":"BFnrneph201546_CR143","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1038\/ncomms3658","volume":"4","author":"M Castelli","year":"2013","unstructured":"Castelli, M. et al. Polycystin-1 binds Par3\/aPKC and controls convergent extension during renal tubular morphogenesis. Nat. Commun. 4, 2658 (2013).","journal-title":"Nat. Commun."},{"key":"BFnrneph201546_CR144","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1091\/mbc.e07-02-0142","volume":"18","author":"M Boca","year":"2007","unstructured":"Boca, M. et al. Polycystin-1 induces cell migration by regulating phosphatidylinositol 3-kinase-dependent cytoskeletal rearrangements and GSK3\u03b2-dependent cell\u2013cell mechanical adhesion. Mol. Biol. Cell 18, 4050\u20134061 (2007).","journal-title":"Mol. Biol. Cell"},{"key":"BFnrneph201546_CR145","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1681\/ASN.2010010127","volume":"21","author":"A Luyten","year":"2010","unstructured":"Luyten, A. et al. Aberrant regulation of planar cell polarity in polycystic kidney disease. J. Am. Soc. Nephrol. 21, 1521\u20131532 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201546_CR146","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1242\/jcs.081406","volume":"124","author":"JC Pease","year":"2011","unstructured":"Pease, J. C. & Tirnauer, J. S. Mitotic spindle misorientation in cancer\u2014out of alignment and into the fire. J. Cell Sci. 124, 1007\u20131016 (2011).","journal-title":"J. Cell Sci."},{"key":"BFnrneph201546_CR147","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/ncb2202","volume":"13","author":"B Delaval","year":"2011","unstructured":"Delaval, B. et al. The cilia protein IFT88 is required for spindle orientation in mitosis. Nat. Cell Biol. 13, 461\u2013468 (2011).","journal-title":"Nat. Cell Biol."},{"key":"BFnrneph201546_CR148","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/ki.2010.534","volume":"79","author":"N Sugiyama","year":"2011","unstructured":"Sugiyama, N. et al. The canonical Wnt signaling pathway is not involved in renal cyst development in the kidneys of inv mutant mice. Kidney Int. 79, 957\u2013965 (2011).","journal-title":"Kidney Int."},{"key":"BFnrneph201546_CR149","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1681\/ASN.2011080829","volume":"23","author":"JA Jonassen","year":"2012","unstructured":"Jonassen, J. A. et al. Disruption of IFT complex A causes cystic kidneys without mitotic spindle misorientation. J. Am. Soc. Nephrol. 23, 641\u2013651 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201546_CR150","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1681\/ASN.2009060603","volume":"21","author":"S Nishio","year":"2010","unstructured":"Nishio, S. et al. Loss of oriented cell division does not initiate cyst formation. J. Am. Soc. Nephrol. 21, 295\u2013302 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201546_CR151","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrm3434","volume":"13","author":"J Massague","year":"2012","unstructured":"Massague, J. TGF\u03b2 signalling in context. Nat. Rev. Mol. Cell Biol. 13, 616\u2013630 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnrneph201546_CR152","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.jmb.2007.03.070","volume":"369","author":"A Markoff","year":"2007","unstructured":"Markoff, A. et al. Annexin A5 interacts with polycystin-1 and interferes with the polycystin-1 stimulated recruitment of E-cadherin into adherens junctions. J. Mol. Biol. 369, 954\u2013966 (2007).","journal-title":"J. Mol. Biol."},{"key":"BFnrneph201546_CR153","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1083\/jcb.149.1.111","volume":"149","author":"AJ Charron","year":"2000","unstructured":"Charron, A. J. et al. Compromised cytoarchitecture and polarized trafficking in autosomal dominant polycystic kidney disease cells. J. Cell Biol. 149, 111\u2013124 (2000).","journal-title":"J. Cell Biol."},{"key":"BFnrneph201546_CR154","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3349\/ymj.2009.50.1.105","volume":"50","author":"SW Chea","year":"2009","unstructured":"Chea, S. W. & Lee, K. B. TGF-\u03b2 mediated epithelial-mesenchymal transition in autosomal dominant polycystic kidney disease. Yonsei Med. J. 50, 105\u2013111 (2009).","journal-title":"Yonsei Med. J."},{"key":"BFnrneph201546_CR155","doi-asserted-by":"publisher","first-page":"F511","DOI":"10.1152\/ajprenal.00038.2010","volume":"300","author":"H Togawa","year":"2011","unstructured":"Togawa, H. et al. Epithelial-to-mesenchymal transition in cyst lining epithelial cells in an orthologous PCK rat model of autosomal-recessive polycystic kidney disease. Am. J. Physiol. Renal Physiol. 300, F511\u2013F520 (2011).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201546_CR156","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1756-9966-31-75","volume":"31","author":"N You","year":"2012","unstructured":"You, N. et al. Tg737 signaling is required for hypoxia-enhanced invasion and migration of hepatoma cells. J. Exp. Clin. Cancer Res. 31, 75 (2012).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"BFnrneph201546_CR157","doi-asserted-by":"publisher","first-page":"12859","DOI":"10.1073\/pnas.1405362111","volume":"111","author":"AS Nikonova","year":"2014","unstructured":"Nikonova, A. S. et al. Nedd9 restrains renal cystogenesis in Pkd1\u2212\/\u2212 mice. Proc. Natl Acad. Sci. USA 111, 12859\u201312864 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201546_CR158","doi-asserted-by":"publisher","first-page":"C522","DOI":"10.1152\/ajpcell.00163.2010","volume":"301","author":"J Elliott","year":"2011","unstructured":"Elliott, J., Zheleznova, N. N. & Wilson, P. D. c-Src inactivation reduces renal epithelial cell-matrix adhesion, proliferation, and cyst formation. Am. J. Physiol. Cell Physiol. 301, C522\u2013529 (2011).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"BFnrneph201546_CR159","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0960-9822(01)00423-7","volume":"11","author":"MM Barr","year":"2001","unstructured":"Barr, M. M. et al. The Caenorhabditis elegans autosomal dominant polycystic kidney disease gene homologs lov-1 and pkd-2 act in the same pathway. Curr. Biol. 11, 1341\u20131346 (2001).","journal-title":"Curr. Biol."},{"key":"BFnrneph201546_CR160","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1097\/01.ASN.0000029587.47950.25","volume":"13","author":"BK Yoder","year":"2002","unstructured":"Yoder, B. K., Hou, X. & Guay-Woodford, L. M. The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia. J. Am. Soc. Nephrol. 13, 2508\u20132516 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201546_CR161","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1056\/NEJMra1010172","volume":"364","author":"F Hildebrandt","year":"2011","unstructured":"Hildebrandt, F., Benzing, T. & Katsanis, N. Ciliopathies. N. Engl. J. Med. 364, 1533\u20131543 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201546_CR162","doi-asserted-by":"publisher","first-page":"F541","DOI":"10.1152\/ajprenal.00273.2001","volume":"282","author":"BK Yoder","year":"2002","unstructured":"Yoder, B. K. et al. Polaris, a protein disrupted in orpk mutant mice, is required for assembly of renal cilium. Am. J. Physiol. Renal Physiol. 282, F541\u2013F552 (2002).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph201546_CR163","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1242\/dev.01240","volume":"131","author":"Z Sun","year":"2004","unstructured":"Sun, Z. et al. A genetic screen in zebrafish identifies cilia genes as a principal cause of cystic kidney. Development 131, 4085\u20134093 (2004).","journal-title":"Development"},{"key":"BFnrneph201546_CR164","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1038\/emboj.2008.96","volume":"27","author":"IJ Frew","year":"2008","unstructured":"Frew, I. J. et al. pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation. EMBO J. 27, 1747\u20131757 (2008).","journal-title":"EMBO J."},{"key":"BFnrneph201546_CR165","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/ng.2715","volume":"45","author":"M Ma","year":"2013","unstructured":"Ma, M. et al. Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease. Nat. Genet. 45, 1004\u20131012 (2013).","journal-title":"Nat. Genet."},{"key":"BFnrneph201546_CR166","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1158\/1078-0432.CCR-11-0755","volume":"18","author":"NB Hassounah","year":"2012","unstructured":"Hassounah, N. B., Bunch, T. A. & McDermott, K. M. Molecular pathways: the role of primary cilia in cancer progression and therapeutics with a focus on Hedgehog signaling. Clin. Cancer Res. 18, 2429\u20132435 (2012).","journal-title":"Clin. Cancer Res."},{"key":"BFnrneph201546_CR167","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1016\/j.ddmec.2013.03.004","volume":"10","author":"T Seeger-Nukpezah","year":"2013","unstructured":"Seeger-Nukpezah, T., Little, J. L., Serzhanova, V. & Golemis, E. A. Cilia and cilia-associated proteins in cancer. Drug Discov. Today Dis. Mech. 10, e135\u2013e142 (2013).","journal-title":"Drug Discov. Today Dis. Mech."},{"key":"BFnrneph201546_CR168","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/modpathol.2008.132","volume":"22","author":"P Schraml","year":"2009","unstructured":"Schraml, P. et al. Sporadic clear cell renal cell carcinoma but not the papillary type is characterized by severely reduced frequency of primary cilia. Mod. Pathol. 22, 31\u201336 (2009).","journal-title":"Mod. Pathol."},{"key":"BFnrneph201546_CR169","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.humpath.2013.11.017","volume":"45","author":"K Emoto","year":"2014","unstructured":"Emoto, K. et al. Presence of primary cilia in cancer cells correlates with prognosis of pancreatic ductal adenocarcinoma. Hum. Pathol. 45, 817\u2013825 (2014).","journal-title":"Hum. Pathol."},{"key":"BFnrneph201546_CR170","doi-asserted-by":"publisher","first-page":"e68521","DOI":"10.1371\/journal.pone.0068521","volume":"8","author":"NB Hassounah","year":"2013","unstructured":"Hassounah, N. B. et al. Primary cilia are lost in preinvasive and invasive prostate cancer. PLoS ONE 8, e68521 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrneph201546_CR171","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2046-2530-3-7","volume":"3","author":"I Menzl","year":"2014","unstructured":"Menzl, I. et al. Loss of primary cilia occurs early in breast cancer development. Cilia 3, 7 (2014).","journal-title":"Cilia"},{"key":"BFnrneph201546_CR172","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1158\/0008-5472.CAN-07-5838","volume":"68","author":"OV Plotnikova","year":"2008","unstructured":"Plotnikova, O. V., Golemis, E. A. & Pugacheva, E. N. Cell cycle-dependent ciliogenesis and cancer. Cancer Res. 68, 2058\u20132061 (2008).","journal-title":"Cancer Res."},{"key":"BFnrneph201546_CR173","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1158\/0008-5472.CAN-12-2938","volume":"73","author":"SA Gradilone","year":"2013","unstructured":"Gradilone, S. A. et al. HDAC6 inhibition restores ciliary expression and decreases tumor growth. Cancer Res. 73, 2259\u20132270 (2013).","journal-title":"Cancer Res."},{"key":"BFnrneph201546_CR174","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/nm.2020","volume":"15","author":"YG Han","year":"2009","unstructured":"Han, Y. G. et al. Dual and opposing roles of primary cilia in medulloblastoma development. Nat. Med. 15, 1062\u20131065 (2009).","journal-title":"Nat. Med."},{"key":"BFnrneph201546_CR175","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.4161\/cc.10.16.17009","volume":"10","author":"S Kim","year":"2011","unstructured":"Kim, S. & Tsiokas, L. Cilia and cell cycle re-entry: more than a coincidence. Cell Cycle 10, 2683\u20132690 (2011).","journal-title":"Cell Cycle"},{"key":"BFnrneph201546_CR176","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s00018-012-1052-z","volume":"70","author":"J Pan","year":"2013","unstructured":"Pan, J., Seeger-Nukpezah, T. & Golemis, E. A. The role of the cilium in normal and abnormal cell cycles: emphasis on renal cystic pathologies. Cell. Mol. Life Sci. 70, 1849\u20131874 (2013).","journal-title":"Cell. Mol. Life Sci."},{"key":"BFnrneph201546_CR177","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00018-012-1073-7","volume":"70","author":"AS Nikonova","year":"2013","unstructured":"Nikonova, A. S. et al. Aurora A kinase (AURKA) in normal and pathological cell division. Cell. Mol. Life Sci. 70, 661\u2013687 (2013).","journal-title":"Cell. Mol. Life Sci."},{"key":"BFnrneph201546_CR178","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.cell.2007.04.035","volume":"129","author":"EN Pugacheva","year":"2007","unstructured":"Pugacheva, E. N. et al. HEF1-dependent Aurora A activation induces disassembly of the primary cilium. Cell 129, 1351\u20131363 (2007).","journal-title":"Cell"},{"issue":"18 Pt 2","key":"BFnrneph201546_CR179","doi-asserted-by":"publisher","first-page":"6290S","DOI":"10.1158\/1078-0432.CCR-sup-040025","volume":"10","author":"WG Kaelin Jr.","year":"2004","unstructured":"Kaelin, W. G. Jr. . The von Hippel-Lindau tumor suppressor gene and kidney cancer. Clin. Cancer Res. 10 (18 Pt 2), 6290S\u20136295S (2004).","journal-title":"Clin. Cancer Res."},{"key":"BFnrneph201546_CR180","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/20459","volume":"399","author":"PH Maxwell","year":"1999","unstructured":"Maxwell, P. H. et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271\u2013275 (1999).","journal-title":"Nature"},{"key":"BFnrneph201546_CR181","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1093\/emboj\/cdg410","volume":"22","author":"X Na","year":"2003","unstructured":"Na, X. et al. Identification of the RNA polymerase II subunit hsRPB7 as a novel target of the von Hippel-Lindau protein. EMBO J. 22, 4249\u20134259 (2003).","journal-title":"EMBO J."},{"key":"BFnrneph201546_CR182","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.semcancer.2012.06.001","volume":"23","author":"C Shen","year":"2013","unstructured":"Shen, C. & Kaelin, W. G. Jr. The VHL\/HIF axis in clear cell renal carcinoma. Semin. Cancer Biol. 23, 18\u201325 (2013).","journal-title":"Semin. Cancer Biol."},{"key":"BFnrneph201546_CR183","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.1158\/0008-5472.CAN-09-2110","volume":"70","author":"SH Kim","year":"2010","unstructured":"Kim, S. H. et al. Human enhancer of filamentation 1 Is a mediator of hypoxia-inducible factor-1\u03b1-mediated migration in colorectal carcinoma cells. Cancer Res. 70, 4054\u20134063 (2010).","journal-title":"Cancer Res."},{"key":"BFnrneph201546_CR184","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1681\/ASN.2010040345","volume":"21","author":"J Xu","year":"2010","unstructured":"Xu, J. et al. VHL inactivation induces HEF1 and Aurora kinase A. J. Am. Soc. Nephrol. 21, 2041\u20132046 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201546_CR185","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.1158\/0008-5472.CAN-07-0391","volume":"67","author":"EW Kuehn","year":"2007","unstructured":"Kuehn, E. W., Walz, G. & Benzing, T. Von hippel-lindau: a tumor suppressor links microtubules to ciliogenesis and cancer development. Cancer Res. 67, 4537\u20134540 (2007).","journal-title":"Cancer Res."},{"key":"BFnrneph201546_CR186","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/ki.1980.148","volume":"18","author":"R Huseman","year":"1980","unstructured":"Huseman, R. et al. Macropuncture study of polycystic disease in adult human kidneys. Kidney Int. 18, 375\u2013385 (1980).","journal-title":"Kidney Int."},{"key":"BFnrneph201546_CR187","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.bbadis.2011.01.011","volume":"1812","author":"S Terryn","year":"2011","unstructured":"Terryn, S. et al. Fluid transport and cystogenesis in autosomal dominant polycystic kidney disease. Biochim. Biophys. Acta 1812, 1314\u20131321 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrneph201546_CR188","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/ki.2008.357","volume":"74","author":"SL Alper","year":"2008","unstructured":"Alper, S. L. Let's look at cysts from both sides now. Kidney Int. 74, 699\u2013702 (2008).","journal-title":"Kidney Int."},{"key":"BFnrneph201546_CR189","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0272-6386(97)90496-0","volume":"30","author":"T Yamaguchi","year":"1997","unstructured":"Yamaguchi, T. et al. Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease. Am. J. Kidney Dis. 30, 703\u2013709 (1997).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph201546_CR190","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.bbadis.2010.11.005","volume":"1812","author":"DP Wallace","year":"2011","unstructured":"Wallace, D. P. Cyclic AMP-mediated cyst expansion. Biochim. Biophys. Acta 1812, 1291\u20131300 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrneph201546_CR191","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1681\/ASN.2005060645","volume":"17","author":"T Yamaguchi","year":"2006","unstructured":"Yamaguchi, T. et al. Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells. J. Am. Soc. Nephrol. 17, 178\u2013187 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201546_CR192","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc2374","volume":"8","author":"HL Roderick","year":"2008","unstructured":"Roderick, H. L. & Cook, S. J. Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival. Nat. Rev. Cancer 8, 361\u2013375 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnrneph201546_CR193","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.1242\/jcs.133751","volume":"126","author":"MG Gold","year":"2013","unstructured":"Gold, M. G., Gonen, T. & Scott, J. D. Local cAMP signaling in disease at a glance. J. Cell Sci. 126, 4537\u20134543 (2013).","journal-title":"J. Cell Sci."},{"key":"BFnrneph201546_CR194","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"VE Torres","year":"2012","unstructured":"Torres, V. E. et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N. Engl. J. Med. 367, 2407\u20132418 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201546_CR195","doi-asserted-by":"publisher","first-page":"c25","DOI":"10.1159\/000334166","volume":"120","author":"MY Chang","year":"2012","unstructured":"Chang, M. Y. & Ong, A. C. Mechanism-based therapeutics for autosomal dominant polycystic kidney disease: recent progress and future prospects. Nephron Clin. Pract. 120, c25\u2013c34 (2012).","journal-title":"Nephron Clin. Pract."},{"key":"BFnrneph201546_CR196","unstructured":"FDA Drug Safety Communication: FDA limits duration and usage of Samsca (tolvaptan) due to possible liver injury leading to organ transplant or death. US Department of Health and Human Services [online] , (2013)."},{"key":"BFnrneph201546_CR197","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3181\/0711-MR-308","volume":"233","author":"H Sontheimer","year":"2008","unstructured":"Sontheimer, H. An unexpected role for ion channels in brain tumor metastasis. Exp. Biol. Med. (Maywood) 233, 779\u2013791 (2008).","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"BFnrneph201546_CR198","doi-asserted-by":"publisher","first-page":"5597","DOI":"10.1158\/0008-5472.CAN-09-4666","volume":"70","author":"BR Haas","year":"2010","unstructured":"Haas, B. R. & Sontheimer, H. Inhibition of the sodium-potassium-chloride cotransporter isoform-1 reduces glioma invasion. Cancer Res. 70, 5597\u20135606 (2010).","journal-title":"Cancer Res."},{"key":"BFnrneph201546_CR199","doi-asserted-by":"publisher","first-page":"e1001320","DOI":"10.1371\/journal.pbio.1001320","volume":"10","author":"T Garzon-Muvdi","year":"2012","unstructured":"Garzon-Muvdi, T. et al. Regulation of brain tumor dispersal by NKCC1 through a novel role in focal adhesion regulation. PLoS Biol. 10, e1001320 (2012).","journal-title":"PLoS Biol."},{"key":"BFnrneph201546_CR200","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.humpath.2012.09.020","volume":"44","author":"MD Johnson","year":"2013","unstructured":"Johnson, M. D. & O'Connell, M. Na-K-2Cl cotransporter and aquaporin 1 in arachnoid granulations, meningiomas, and meningiomas invading dura. Hum. Pathol. 44, 1118\u20131124 (2013).","journal-title":"Hum. Pathol."},{"key":"BFnrneph201546_CR201","doi-asserted-by":"publisher","first-page":"e773","DOI":"10.1038\/cddis.2013.279","volume":"4","author":"G D'Alessandro","year":"2013","unstructured":"D'Alessandro, G. et al. KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo. Cell Death Dis. 4, e773 (2013).","journal-title":"Cell Death Dis."},{"key":"BFnrneph201546_CR202","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00109-008-0303-9","volume":"86","author":"AS Verkman","year":"2008","unstructured":"Verkman, A. S., Hara-Chikuma, M. & Papadopoulos, M. C. Aquaporins\u2014new players in cancer biology. J. Mol. Med. (Berl.) 86, 523\u2013529 (2008).","journal-title":"J. Mol. Med. (Berl.)"},{"key":"BFnrneph201546_CR203","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1038\/onc.2012.251","volume":"32","author":"C Xie","year":"2013","unstructured":"Xie, C. et al. CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer. Oncogene 32, 2282\u20132291 (2013).","journal-title":"Oncogene"},{"key":"BFnrneph201546_CR204","first-page":"1866","volume":"58","author":"WG North","year":"1998","unstructured":"North, W. G. et al. Expression of all known vasopressin receptor subtypes by small cell tumors implies a multifaceted role for this neuropeptide. Cancer Res. 58, 1866\u20131871 (1998).","journal-title":"Cancer Res."},{"key":"BFnrneph201546_CR205","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000030474","volume":"64","author":"AK Hemal","year":"2000","unstructured":"Hemal, A. K. et al. Renal cell carcinoma in cases of adult polycystic kidney disease: changing diagnostic and therapeutic implications. Urol. Int. 64, 9\u201312 (2000).","journal-title":"Urol. Int."},{"key":"BFnrneph201546_CR206","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1681\/ASN.V491661","volume":"4","author":"DS Keith","year":"1994","unstructured":"Keith, D. S. et al. Renal cell carcinoma in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 4, 1661\u20131669 (1994).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201546_CR207","doi-asserted-by":"publisher","first-page":"400","DOI":"10.5858\/arpa.2011-0485-RA","volume":"136","author":"YB Chen","year":"2012","unstructured":"Chen, Y. B. & Tickoo, S. K. Spectrum of preneoplastic and neoplastic cystic lesions of the kidney. Arch. Pathol. Lab. Med. 136, 400\u2013409 (2012).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"BFnrneph201546_CR208","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/ndt\/gfr467","volume":"27","author":"B Orskov","year":"2012","unstructured":"Orskov, B. et al. Changes in causes of death and risk of cancer in Danish patients with autosomal dominant polycystic kidney disease and end-stage renal disease. Nephrol. Dial. Transplant. 27, 1607\u20131613 (2012).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph201546_CR209","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","volume":"359","author":"JJ Grantham","year":"2008","unstructured":"Grantham, J. J. Clinical practice. Autosomal dominant polycystic kidney disease. N. Engl. J. Med. 359, 1477\u20131485 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201546_CR210","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.2215\/CJN.02020309","volume":"4","author":"SM Bonsib","year":"2009","unstructured":"Bonsib, S. M. Renal cystic diseases and renal neoplasms: a mini-review. Clin. J. Am. Soc. Nephrol. 4, 1998\u20132007 (2009).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph201546_CR211","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.urology.2009.02.078","volume":"74","author":"P Hajj","year":"2009","unstructured":"Hajj, P. et al. Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure. Urology 74, 631\u2013634 (2009).","journal-title":"Urology"},{"key":"BFnrneph201546_CR212","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1681\/ASN.2013101122","volume":"25","author":"JB Wetmore","year":"2014","unstructured":"Wetmore, J. B. et al. Polycystic kidney disease and cancer after renal transplantation. J. Am. Soc. Nephrol. 25, 2335\u20132341 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201546_CR213","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00439-011-0950-8","volume":"129","author":"CJ Ward","year":"2011","unstructured":"Ward, C. J. et al. Germline PKHD1 mutations are protective against colorectal cancer. Hum. Genet. 129, 345\u2013349 (2011).","journal-title":"Hum. Genet."},{"key":"BFnrneph201546_CR214","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1002\/ijc.29140","volume":"136","author":"AN Gargalionis","year":"2014","unstructured":"Gargalionis, A. N. et al. Polycystin-1 and polycystin-2 are involved in the acquisition of aggressive phenotypes in colorectal cancer. Int. J. Cancer 136, 1515\u20131527 (2014).","journal-title":"Int. J. Cancer"},{"key":"BFnrneph201546_CR215","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.eururo.2014.04.029","volume":"67","author":"B Shuch","year":"2014","unstructured":"Shuch, B. et al. Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity. Eur. Urol. 67, 85\u201397 (2014).","journal-title":"Eur. Urol."},{"key":"BFnrneph201546_CR216","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1097\/PAS.0b013e318299f2d1","volume":"37","author":"JR Srigley","year":"2013","unstructured":"Srigley, J. R. et al. The International Society of Urological Pathology (ISUP) Vancouver Classification of renal neoplasia. Am. J. Surg. Pathol. 37, 1469\u20131489 (2013).","journal-title":"Am. J. Surg. Pathol."},{"key":"BFnrneph201546_CR217","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0011-5029(05)80007-0","volume":"41","author":"JR Martinez","year":"1995","unstructured":"Martinez, J. R. & Grantham, J. J. Polycystic kidney disease: etiology, pathogenesis, and treatment. Dis. Mon. 41, 693\u2013765 (1995).","journal-title":"Dis. Mon."},{"key":"BFnrneph201546_CR218","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-3-642-21858-3_2","volume-title":"Kidney Cancer: Principles and Practice","author":"K Sircar","year":"2012","unstructured":"Sircar, K. & Tamboli, P. in Kidney Cancer: Principles and Practice (eds. Lara, P. N. Jr & Jonasch, E.) 17\u201328 (Springer\u2013Verlag, 2012)."},{"key":"BFnrneph201546_CR219","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/ki.1997.3","volume":"51","author":"HP Neumann","year":"1997","unstructured":"Neumann, H. P. & Zbar, B. Renal cysts, renal cancer and von Hippel-Lindau disease. Kidney Int. 51, 16\u201326 (1997).","journal-title":"Kidney Int."},{"key":"BFnrneph201546_CR220","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/j.1464-410X.2005.05442.x","volume":"95","author":"KS Warren","year":"2005","unstructured":"Warren, K. S. & McFarlane, J. The Bosniak classification of renal cystic masses. BJU Int. 95, 939\u2013942 (2005).","journal-title":"BJU Int."},{"key":"BFnrneph201546_CR221","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/1477-7819-11-158","volume":"11","author":"J Zhang","year":"2013","unstructured":"Zhang, J. et al. Diagnosis and treatment of cystic renal cell carcinoma. World J. Surg. Oncol. 11, 158 (2013).","journal-title":"World J. Surg. Oncol."},{"key":"BFnrneph201546_CR222","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.juro.2014.07.099","volume":"192","author":"C Ellimoottil","year":"2014","unstructured":"Ellimoottil, C. et al. New modalities for the evaluation and surveillance of complex renal cysts. J. Urol. 192, 1604\u20131611 (2014).","journal-title":"J. Urol."},{"key":"BFnrneph201546_CR223","unstructured":"The National Cancer Institute and National Human Genome Research Institute. The Cancer Genome Atlas [online] , (2015)."},{"key":"BFnrneph201546_CR224","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1681\/ASN.2008040435","volume":"20","author":"AP Bastos","year":"2009","unstructured":"Bastos, A. P. et al. Pkd1 haploinsufficiency increases renal damage and induces microcyst formation following ischemia\/reperfusion. J. Am. Soc. Nephrol. 20, 2389\u20132402 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201546_CR225","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/ng.3146","volume":"47","author":"S Durinck","year":"2014","unstructured":"Durinck, S. et al. Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes. Nat. Genet. 47, 13\u201321. (2014).","journal-title":"Nat. Genet."},{"key":"BFnrneph201546_CR226","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1126\/science.8493574","volume":"260","author":"F Latif","year":"1993","unstructured":"Latif, F. et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260, 1317\u20131320 (1993).","journal-title":"Science"},{"key":"BFnrneph201546_CR227","doi-asserted-by":"publisher","first-page":"7582","DOI":"10.1158\/1078-0432.CCR-09-2131","volume":"15","author":"AC Young","year":"2009","unstructured":"Young, A. C. et al. Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma. Clin. Cancer Res. 15, 7582\u20137592 (2009).","journal-title":"Clin. Cancer Res."},{"key":"BFnrneph201546_CR228","doi-asserted-by":"publisher","first-page":"4726","DOI":"10.1158\/1078-0432.CCR-07-4921","volume":"14","author":"ML Nickerson","year":"2008","unstructured":"Nickerson, M. L. et al. Improved identification of von Hippel\u2013Lindau gene alterations in clear cell renal tumors. Clin. Cancer Res. 14, 4726\u20134734 (2008).","journal-title":"Clin. Cancer Res."},{"key":"BFnrneph201546_CR229","unstructured":"Surveillance, Epidemiology, and End Results Program. SEER stat fact sheets: kidney and renal pelvis cancer. National Cancer Institute [online] , (2014)."},{"key":"BFnrneph201546_CR230","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/S0046-8177(88)80089-3","volume":"19","author":"D Solomon","year":"1988","unstructured":"Solomon, D. & Schwartz, A. Renal pathology in von Hippel-Lindau disease. Hum. Pathol. 19, 1072\u20131079 (1988).","journal-title":"Hum. Pathol."},{"key":"BFnrneph201546_CR231","first-page":"2089","volume":"149","author":"IA Lubensky","year":"1996","unstructured":"Lubensky, I. A. et al. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel\u2013Lindau disease patients. Am. J. Pathol. 149, 2089\u20132094 (1996).","journal-title":"Am. J. Pathol."},{"key":"BFnrneph201546_CR232","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1535-6108(02)00071-5","volume":"1","author":"SJ Mandriota","year":"2002","unstructured":"Mandriota, S. J. et al. HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron. Cancer Cell 1, 459\u2013468 (2002).","journal-title":"Cancer Cell"},{"key":"BFnrneph201546_CR233","doi-asserted-by":"crossref","unstructured":"Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499, 43\u201349 (2013).","DOI":"10.1038\/nature12222"},{"key":"BFnrneph201546_CR234","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1097\/PAS.0b013e3181ddf54d","volume":"34","author":"M Montani","year":"2010","unstructured":"Montani, M. et al. VHL-gene deletion in single renal tubular epithelial cells and renal tubular cysts: further evidence for a cyst-dependent progression pathway of clear cell renal carcinoma in von Hippel\u2013Lindau disease. Am. J. Surg. Pathol. 34, 806\u2013815 (2010).","journal-title":"Am. J. Surg. Pathol."},{"key":"BFnrneph201546_CR235","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/ng.2699","volume":"45","author":"Y Sato","year":"2013","unstructured":"Sato, Y. et al. Integrated molecular analysis of clear-cell renal cell carcinoma. Nat. Genet. 45, 860\u2013867 (2013).","journal-title":"Nat. Genet."},{"key":"BFnrneph201546_CR236","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nature09639","volume":"469","author":"I Varela","year":"2011","unstructured":"Varela, I. et al. Exome sequencing identifies frequent mutation of the SWI\/SNF complex gene PBRM1 in renal carcinoma. Nature 469, 539\u2013542 (2011).","journal-title":"Nature"},{"key":"BFnrneph201546_CR237","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/ng.2323","volume":"44","author":"S Pena-Llopis","year":"2012","unstructured":"Pena-Llopis, S. et al. BAP1 loss defines a new class of renal cell carcinoma. Nat. Genet. 44, 751\u2013759 (2012).","journal-title":"Nat. Genet."},{"key":"BFnrneph201546_CR238","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1158\/0008-5472.CAN-10-0120","volume":"70","author":"G Duns","year":"2010","unstructured":"Duns, G. et al. Histone methyltransferase gene SETD2 is a novel tumor suppressor gene in clear cell renal cell carcinoma. Cancer Res. 70, 4287\u20134291 (2010).","journal-title":"Cancer Res."},{"key":"BFnrneph201546_CR239","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/gcc.22116","volume":"53","author":"L Gossage","year":"2014","unstructured":"Gossage, L. et al. Clinical and pathological impact of VHL, PBRM1, BAP1, SETD2, KDM6A, and JARID1c in clear cell renal cell carcinoma. Genes Chromosomes Cancer 53, 38\u201351 (2014).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFnrneph201546_CR240","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1053\/j.gastro.2007.11.035","volume":"134","author":"SA McDonald","year":"2008","unstructured":"McDonald, S. A. et al. Mechanisms of field cancerization in the human stomach: the expansion and spread of mutated gastric stem cells. Gastroenterology 134, 500\u2013510 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrneph201546_CR241","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/path.4408","volume":"234","author":"NA Wright","year":"2014","unstructured":"Wright, N. A. Boveri at 100: cancer evolution, from preneoplasia to malignancy. J. Pathol. 234, 146\u2013151 (2014).","journal-title":"J. Pathol."},{"key":"BFnrneph201546_CR242","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.humpath.2012.09.022","volume":"44","author":"MP Foschini","year":"2013","unstructured":"Foschini, M. P. et al. Genetic clonal mapping of in situ and invasive ductal carcinoma indicates the field cancerization phenomenon in the breast. Hum. Pathol. 44, 1310\u20131319 (2013).","journal-title":"Hum. Pathol."},{"key":"BFnrneph201546_CR243","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1172\/JCI72589","volume":"124","author":"GP Dotto","year":"2014","unstructured":"Dotto, G. P. Multifocal epithelial tumors and field cancerization: stroma as a primary determinant. J. Clin. Invest. 124, 1446\u20131453 (2014).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph201546_CR244","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","volume":"61","author":"ER Fearon","year":"1990","unstructured":"Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell 61, 759\u2013767 (1990).","journal-title":"Cell"},{"key":"BFnrneph201546_CR245","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/annurev-physiol-030212-183705","volume":"75","author":"J Hou","year":"2013","unstructured":"Hou, J., Rajagopal, M. & Yu, A. S. Claudins and the kidney. Annu. Rev. Physiol. 75, 479\u2013501 (2013).","journal-title":"Annu. Rev. Physiol."},{"key":"BFnrneph201546_CR246","first-page":"180","volume":"114","author":"A Ramos","year":"1990","unstructured":"Ramos, A. et al. The liver in autosomal dominant polycystic kidney disease. Implications for pathogenesis. Arch. Pathol. Lab. Med. 114, 180\u2013184 (1990).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"BFnrneph201546_CR247","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/path.2392","volume":"216","author":"AS Yu","year":"2008","unstructured":"Yu, A. S. et al. Tight junction composition is altered in the epithelium of polycystic kidneys. J. Pathol. 216, 120\u2013128 (2008).","journal-title":"J. Pathol."},{"key":"BFnrneph201546_CR248","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.canlet.2013.05.038","volume":"337","author":"EA Runkle","year":"2013","unstructured":"Runkle, E. A. & Mu, D. Tight junction proteins: from barrier to tumorigenesis. Cancer Lett. 337, 41\u201348 (2013).","journal-title":"Cancer Lett."},{"key":"BFnrneph201546_CR249","doi-asserted-by":"publisher","first-page":"18148","DOI":"10.3390\/ijms140918148","volume":"14","author":"MJ Kwon","year":"2013","unstructured":"Kwon, M. J. Emerging roles of claudins in human cancer. Int. J. Mol. Sci. 14, 18148\u201318180 (2013).","journal-title":"Int. J. Mol. Sci."},{"key":"BFnrneph201546_CR250","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.humpath.2008.07.002","volume":"40","author":"AO Osunkoya","year":"2009","unstructured":"Osunkoya, A. O. et al. Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma. Hum. Pathol. 40, 206\u2013210 (2009).","journal-title":"Hum. Pathol."},{"key":"BFnrneph201546_CR251","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.oraloncology.2013.07.008","volume":"49","author":"LJ Melchers","year":"2013","unstructured":"Melchers, L. J. et al. Lack of claudin-7 is a strong predictor of regional recurrence in oral and oropharyngeal squamous cell carcinoma. Oral Oncol. 49, 998\u20131005 (2013).","journal-title":"Oral Oncol."},{"key":"BFnrneph201546_CR252","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1471-2407-11-65","volume":"11","author":"J Bornholdt","year":"2011","unstructured":"Bornholdt, J. et al. The level of claudin-7 is reduced as an early event in colorectal carcinogenesis. BMC Cancer 11, 65 (2011).","journal-title":"BMC Cancer"},{"key":"BFnrneph201546_CR253","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nature11465","volume":"491","author":"SI Grivennikov","year":"2012","unstructured":"Grivennikov, S. I. et al. Adenoma-linked barrier defects and microbial products drive IL-23\/IL-17-mediated tumour growth. Nature 491, 254\u2013258 (2012).","journal-title":"Nature"},{"key":"BFnrneph201546_CR254","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nrurol.2014.129","volume":"11","author":"W Choi","year":"2014","unstructured":"Choi, W. et al. Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer. Nat. Rev. Urol. 11, 400\u2013410 (2014).","journal-title":"Nat. Rev. Urol."},{"key":"BFnrneph201546_CR255","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1091\/mbc.e08-06-0566","volume":"20","author":"SK Harten","year":"2009","unstructured":"Harten, S. K. et al. Regulation of renal epithelial tight junctions by the von Hippel\u2013Lindau tumor suppressor gene involves occludin and claudin 1 and is independent of E-cadherin. Mol. Biol. Cell 20, 1089\u20131101 (2009).","journal-title":"Mol. Biol. Cell"},{"key":"BFnrneph201546_CR256","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ajpath.2013.09.007","volume":"184","author":"D De Nardo","year":"2014","unstructured":"De Nardo, D., De Nardo, C. M. & Latz, E. New insights into mechanisms controlling the NLRP3 inflammasome and its role in lung disease. Am. J. Pathol. 184, 42\u201354 (2014).","journal-title":"Am. J. Pathol."},{"key":"BFnrneph201546_CR257","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/01.mnh.0000444814.49755.90","volume":"23","author":"A Chang","year":"2014","unstructured":"Chang, A., Ko, K. & Clark, M. R. The emerging role of the inflammasome in kidney diseases. Curr. Opin. Nephrol. Hypertens. 23, 204\u2013210 (2014).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"BFnrneph201546_CR258","doi-asserted-by":"publisher","first-page":"R43","DOI":"10.1016\/j.cub.2011.11.004","volume":"22","author":"J Settleman","year":"2012","unstructured":"Settleman, J. Oncogene addiction. Curr. Biol. 22, R43\u2013R44 (2012).","journal-title":"Curr. Biol."},{"key":"BFnrneph201546_CR259","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1101\/gad.1609907","volume":"21","author":"SV Sharma","year":"2007","unstructured":"Sharma, S. V. & Settleman, J. Oncogene addiction: setting the stage for molecularly targeted cancer therapy. Genes Dev. 21, 3214\u20133231 (2007).","journal-title":"Genes Dev."},{"key":"BFnrneph201546_CR260","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","volume":"146","author":"JE Delmore","year":"2011","unstructured":"Delmore, J. E. et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146, 904\u2013917 (2011).","journal-title":"Cell"},{"key":"BFnrneph201546_CR261","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/ncb2491","volume":"14","author":"H Liu","year":"2012","unstructured":"Liu, H. et al. MYC suppresses cancer metastasis by direct transcriptional silencing of \u03b1v and \u03b23 integrin subunits. Nat. Cell Biol. 14, 567\u2013574 (2012).","journal-title":"Nat. Cell Biol."},{"key":"BFnrneph201546_CR262","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1073\/pnas.1011498108","volume":"108","author":"V Takiar","year":"2011","unstructured":"Takiar, V. et al. Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis. Proc. Natl Acad. Sci. USA 108, 2462\u20132467 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph201546_CR263","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrendo.2013.256","volume":"10","author":"I Pernicova","year":"2014","unstructured":"Pernicova, I. & Korbonits, M. Metformin\u2014mode of action and clinical implications for diabetes and cancer. Nat. Rev. Endocrinol. 10, 143\u2013156 (2014).","journal-title":"Nat. Rev. Endocrinol."},{"key":"BFnrneph201546_CR264","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1586\/17512433.2014.862496","volume":"7","author":"TB Dorff","year":"2014","unstructured":"Dorff, T. B., Pal, S. K. & Quinn, D. I. Novel tyrosine kinase inhibitors for renal cell carcinoma. Expert Rev. Clin. Pharmacol. 7, 67\u201373 (2014).","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"BFnrneph201546_CR265","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11912-013-0299-3","volume":"15","author":"TF Logan","year":"2013","unstructured":"Logan, T. F. Foretinib (XL880): c-MET inhibitor with activity in papillary renal cell cancer. Curr. Oncol. Rep. 15, 83\u201390 (2013).","journal-title":"Curr. Oncol. Rep."},{"key":"BFnrneph201546_CR266","unstructured":"American Cancer Society. Cancer Facts & Figures 2014. cancer.org [online] , (2014)."},{"key":"BFnrneph201546_CR267","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1001\/jama.291.20.2441","volume":"291","author":"JF Piccirillo","year":"2004","unstructured":"Piccirillo, J. F. et al. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 291, 2441\u20132447 (2004).","journal-title":"JAMA"},{"key":"BFnrneph201546_CR268","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1056\/NEJMoa1402686","volume":"371","author":"VE Torres","year":"2014","unstructured":"Torres, V. E. et al. Angiotensin blockade in late autosomal dominant polycystic kidney disease. N. Engl. J. Med. 371, 2267\u20132276 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201546_CR269","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","volume":"371","author":"RW Schrier","year":"2014","unstructured":"Schrier, R. W. et al. Blood pressure in early autosomal dominant polycystic kidney disease. N. Engl. J. Med. 371, 2255\u20132266 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201546_CR270","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1056\/NEJMe1412586","volume":"371","author":"DH Ellison","year":"2014","unstructured":"Ellison, D. H. & Ingelfinger, J. R. A quest\u2014halting the progression of autosomal dominant polycystic kidney disease. N. Engl. J. Med. 371, 2329\u20132331 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph201546_CR271","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.critrevonc.2014.08.004","volume":"93","author":"S Abi Aad","year":"2015","unstructured":"Abi Aad, S. et al. Hypertension induced by chemotherapeutic and immunosuppresive agents: A new challenge. Crit. Rev. Oncol. Hematol. 93, 28\u201335 (2015).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"BFnrneph201546_CR272","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1161\/01.HYP.28.3.321","volume":"28","author":"P Hamet","year":"1996","unstructured":"Hamet, P. Cancer and hypertension. An unresolved issue. Hypertension 28, 321\u2013324 (1996).","journal-title":"Hypertension"},{"key":"BFnrneph201546_CR273","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1161\/HYPERTENSIONAHA.113.02953","volume":"63","author":"KM Sanfilippo","year":"2014","unstructured":"Sanfilippo, K. M. et al. Hypertension and obesity and the risk of kidney cancer in 2 large cohorts of US men and women. Hypertension 63, 934\u2013941 (2014).","journal-title":"Hypertension"},{"key":"BFnrneph201546_CR274","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.amjcard.2011.03.038","volume":"108","author":"I Sipahi","year":"2011","unstructured":"Sipahi, I. et al. Meta-analysis of randomized controlled trials on effect of angiotensin-converting enzyme inhibitors on cancer risk. Am. J. Cardiol. 108, 294\u2013301 (2011).","journal-title":"Am. J. Cardiol."},{"key":"BFnrneph201546_CR275","first-page":"221","volume":"43","author":"GM Piersol","year":"1927","unstructured":"Piersol, G. M. Polycystic Disease of the Kidney. Trans. Am. Climatol. Clin. Assoc. 43, 221\u2013231 (1927).","journal-title":"Trans. Am. Climatol. Clin. Assoc."},{"key":"BFnrneph201546_CR276","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1681\/ASN.2006121387","volume":"18","author":"S Rossetti","year":"2007","unstructured":"Rossetti, S. et al. Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 18, 2143\u20132160 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201546_CR277","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1002\/humu.22103","volume":"33","author":"MP Audrezet","year":"2012","unstructured":"Audrezet, M. P. et al. Autosomal dominant polycystic kidney disease: comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients. Hum. Mutat. 33, 1239\u20131250 (2012).","journal-title":"Hum. Mutat."},{"key":"BFnrneph201546_CR278","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1681\/ASN.2012070650","volume":"24","author":"E Cornec-Le Gall","year":"2013","unstructured":"Cornec-Le Gall, E. et al. Type of PKD1 mutation influences renal outcome in ADPKD. J. Am. Soc. Nephrol. 24, 1006\u20131013 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph201546_CR279","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-21858-3","volume-title":"Kidney Cancer: Principles and Practice","author":"PN Lara Jr","year":"2012","unstructured":"Lara, P. N. Jr & Jonasch, E. (Eds) Kidney Cancer: Principles and Practice. (Springer\u2013Verlag, 2012)."},{"key":"BFnrneph201546_CR280","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1200\/JCO.2009.23.0045","volume":"27","author":"WM Linehan","year":"2009","unstructured":"Linehan, W. M. Genetic basis of bilateral renal cancer: implications for evaluation and management. J. Clin. Oncol. 27, 3731\u20133733 (2009).","journal-title":"J. Clin. Oncol."},{"key":"BFnrneph201546_CR281","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1177\/1756287213505672","volume":"5","author":"JP Dutcher","year":"2013","unstructured":"Dutcher, J. P. Recent developments in the treatment of renal cell carcinoma. Ther. Adv. Urol. 5, 338\u2013353 (2013).","journal-title":"Ther. Adv. Urol."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2015.46.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2015.46","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2015.46.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:47:02Z","timestamp":1684471622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2015.46"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,14]]},"references-count":281,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["BFnrneph201546"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2015.46","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,14]]},"assertion":[{"value":"14 April 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}